Thoracic surgery Surgery
Conditions
Interventions
Continuous thoracic epidural catheter or continuous paravertebral catheter for pain treatment
Sponsors
Saarland University Medical Center and Saarland University Faculty of Medicine (Germany)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 18 years old and above 2. American Society of Anesthesiologists (ASA) grade I-III 3. Planned thoracic surgery 4. Accepted procedure
Exclusion criteria
Exclusion criteria: 1. Relevant liver or renal disease (Kreatinin > 2 mg/dl, Bilirubin > 2 mg/dl) 2. Inability to communicate 3. Relevant cardiac or neurological disease 4. Chronic treatment with opioids or psychiatric drugs 5. Dependencies 6. Body Mass Index > 30 7. ASA > III 8. Contraindication for a neuraxial procedure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FV1 measured in L/sec and PEF measured in L/sec- lung function parameters from spirometry (FeV1=expiratory flow after 1 second, PEF=peak expiratory flow, FVC=forced vital capacity). The outcome parameters will be measured before the TEA or PVB placement, 15 minutes afterwards and twice daily until day 3 after surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Pain levels at rest and with coughing (using the verbal numeric rating scale at rest and during coughing) 2. Aggregated incidence of nausea, vomiting, pneumonia, atelectases 3. Mobilisation (time to stand up, to walk) The outcome parameters will be measured before the TEA or PVB placement, 15 minutes afterwards and twice daily until day 3 after surgery. | — |
Countries
Germany
Outcome results
None listed